Showing results (381-390 of 397) with videos related to

Sort By:
Pageof 40
Molecular Therapy Oncolytics|September 13, 2023
Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing miceCarolin Kitzberger, Khuram Shehzad, Volker Morath, et al.
Oncotarget|July 27, 2016
Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene deliveryAndrea M Müller, Kathrin A Schmohl, Kerstin Knoop, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2022
Mesenchymal Stem Cell-mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing MiceCarolin Kitzberger, Rebekka Spellerberg, Yang Han, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2020
Substituted sulfonamide bioisosteres of 8-hydroxyquinoline as zinc-dependent antibacterial compoundsJohn E McGowan, Andrew D Harper, Emma K Davison, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 13, 2022
Endothelial Retargeting of AAV9 In VivoTarik Bozoglu, Seungmin Lee, Tilman Ziegler, et al.
EJNMMI Research|May 3, 2022
The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapyCarolin Kitzberger, Rebekka Spellerberg, Volker Morath, et al.
Cell Death & Disease|April 5, 2019
Targeting actin inhibits repair of doxorubicin-induced DNA damage: a novel therapeutic approach for combination therapyLisa Pfitzer, Christina Moser, Florian Gegenfurtner, et al.
Theranostics|April 16, 2020
Effective control of tumor growth through spatial and temporal control of theranostic sodium iodide symporter (NIS) gene expression using a heat-inducible gene promoter in engineered mesenchymal stem cellsMariella Tutter, Christina Schug, Kathrin A Schmohl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 17, 2020
Regional Hyperthermia Enhances Mesenchymal Stem Cell Recruitment to Tumor Stroma: Implications for Mesenchymal Stem Cell-Based Tumor TherapyMariella Tutter, Christina Schug, Kathrin A Schmohl, et al.
Molecular Therapy Oncolytics|December 2, 2021
Selective sodium iodide symporter (NIS) genetherapy of glioblastoma mediatedby EGFR-targeted lipopolyplexesRebekka Spellerberg, Teoman Benli-Hoppe, Carolin Kitzberger, et al.
Pageof 40